메디컬 에스테틱 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of medical aesthetics Market

The global medical aesthetics market was valued at USD 28.49 billion in 2025 and is projected to grow to USD 31.96 billion in 2026, reaching USD 89.59 billion by 2034, exhibiting a strong CAGR of 13.75% during the forecast period (2026-2034). North America dominated the market with a 54.87% share in 2025, driven by high demand for cosmetic procedures and the presence of advanced healthcare infrastructure.

Medical aesthetics includes a wide range of minimally invasive and non-invasive cosmetic procedures such as dermal fillers, botulinum toxin treatments, laser therapies, and body contouring solutions. The market is witnessing rapid expansion due to growing awareness, increasing disposable income, and technological advancements.

Market Trends

A major trend shaping the market is the rising demand for minimally invasive procedures such as botulinum toxin and dermal fillers. These procedures offer benefits like reduced recovery time, minimal pain, and fewer side effects, making them highly preferred over traditional surgeries.

Additionally, the growing adoption among male consumers is expanding the customer base. The demand for facial aesthetics and anti-aging treatments is increasing globally, supported by social media influence and rising beauty consciousness.

Market Growth Drivers

Rising Popularity of Non-Surgical Procedures

The increasing preference for non-invasive treatments is a key driver of market growth. Procedures such as fillers and chemical peels are widely used for wrinkle reduction, skin rejuvenation, and scar treatment.

Growing Demand for Home-Based Aesthetic Devices

Technological advancements have led to the introduction of home-use devices such as LED and radiofrequency-based tools. These solutions provide convenience and affordability, boosting adoption among consumers.

Increasing Disposable Income

Emerging economies such as India, China, and Brazil are witnessing rising income levels, enabling consumers to spend more on aesthetic treatments and personal care.

Market Restraints

Despite strong growth, the market faces challenges such as the high cost of aesthetic devices and procedures. Advanced equipment can cost between USD 120,000 and USD 300,000, limiting accessibility for smaller clinics.

Additionally, the lack of reimbursement policies and the need for repeated treatments (e.g., botulinum toxin every 4-6 months) increase the overall cost burden on patients, restraining market expansion.

Segmentation Analysis

By Type

The market is segmented into energy-based devices and non-energy-based devices.

• The non-energy-based segment dominated with a 62.42% share in 2026, driven by high demand for dermal fillers and botulinum toxin.
• Energy-based devices are expected to grow steadily due to innovations in laser and ultrasound technologies.

By Application

Key segments include skin resurfacing, body contouring, hair removal, and others.

• Skin resurfacing & tightening led the market with a 44.16% share in 2026, due to increasing demand for anti-aging treatments.
• Hair removal and tattoo removal segments are also witnessing rising adoption.

By End-User

The market is divided into hospitals, specialty clinics, and others.

• Specialty clinics dominated with a 40.49% share in 2026, owing to increasing patient preference for specialized aesthetic services.

Regional Insights

North America

North America led the market with USD 15.63 billion in 2025 and is expected to reach USD 17.73 billion in 2026. Growth is driven by a high number of procedures and skilled professionals.

Asia Pacific

The region recorded USD 5.36 billion in 2025 and is projected to reach USD 6.03 billion in 2026. Increasing demand in countries like China, India, and Japan is fueling growth.

Europe

Europe accounted for USD 5.4 billion in 2025 and is expected to grow to USD 5.95 billion in 2026, supported by medical tourism and rising adoption of non-invasive procedures.

Rest of the World

Latin America and the Middle East & Africa are emerging markets, driven by improving healthcare infrastructure and rising demand for cosmetic treatments.

Competitive Landscape

Key players in the market include Sisram Medical Ltd., Merz Pharma, AbbVie Inc., Apyx Medical, Cutera, and Candela Medical. These companies are focusing on product innovation, regulatory approvals, and strategic acquisitions to strengthen their market position.

Conclusion

The medical aesthetics market is experiencing rapid growth, driven by the increasing demand for minimally invasive procedures, technological advancements, and rising consumer awareness. With the market expanding from USD 28.49 billion in 2025 to USD 89.59 billion by 2034, the industry presents significant opportunities for innovation and investment. However, high treatment costs and lack of reimbursement policies remain key challenges. Overall, the market is set for strong long-term growth, supported by evolving consumer preferences and continuous advancements in aesthetic technologies.

Segmentation By Type

• Energy-based Aesthetic Devices
• Laser-based Aesthetic Devices
• Radiofrequency-based Aesthetic Devices
• Light-based Aesthetic Devices
• Ultrasound Aesthetic Devices
• Non-energy-based Aesthetic Devices
• Botulinum Toxin
• Dermal Fillers
• Microdermabrasion
• Implants
• Dental Implants
• Breast Implants
• Other Implants
• Others

By Application

• Skin Resurfacing & Tightening
• Body Contouring and Cellulite Reduction
• Hair and Tattoo Removal
• Breast Augmentation
• Other Applications

By End-user

• Hospitals
• Specialty Clinics
• Others

By Region

• North America (By Type, By Application, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Type, By Application, By End-user, and By Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region)
  • India
  • China
  • Japan
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Application, By End-user, and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Application, By End-user, and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Total Number of Aesthetic Procedures- Invasive & Non-Invasive, By Key Countries, 2025/2025
• 4.2. Technological Advancements in Medical Aesthetic Devices
• 4.3. New Product Launches, By Key Players
• 4.4. Key Industry Developments- Mergers, Partnerships, & Acquisitions
• 4.5. Impact of COVID-19 on the Market

5. Global Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Energy-based Aesthetic Devices
    • 5.1.1.1. Laser-based Aesthetic Devices
    • 5.1.1.2. Radiofrequency based Aesthetic Devices
    • 5.1.1.3. Light-based Aesthetic Devices
    • 5.1.1.4. Ultrasound Aesthetic Devices
  • 5.1.2. Non-Energy based Aesthetic Devices
    • 5.1.2.1. Botulinum Toxin
    • 5.1.2.2. Dermal Fillers
    • 5.1.2.3. Microdermabrasion
    • 5.1.2.4. Implants
      • 5.1.2.4.1. Dental Implants
      • 5.1.2.4.2. Breast Implants
      • 5.1.2.4.3. Other Implants
  • 5.1.3. Other Aesthetic Devices
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Skin Resurfacing & Tightening
  • 5.2.2. Body Contouring and Cellulite Reduction
  • 5.2.3. Hair and Tattoo Removal
  • 5.2.4. Breast Augmentation
  • 5.2.5. Other Applications
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Energy-based Aesthetic Devices
    • 6.1.1.1. Laser-based Aesthetic Devices
    • 6.1.1.2. Radiofrequency based Aesthetic Devices
    • 6.1.1.3. Light-based Aesthetic Devices
    • 6.1.1.4. Ultrasound Aesthetic Devices
  • 6.1.2. Non-Energy based Aesthetic Devices
    • 6.1.2.1. Botulinum Toxin
    • 6.1.2.2. Dermal Fillers
    • 6.1.2.3. Microdermabrasion
    • 6.1.2.4. Implants
      • 6.1.2.4.1. Dental Implants
      • 6.1.2.4.2. Breast Implants
      • 6.1.2.4.3. Other Implants
  • 6.1.3. Other Aesthetic Devices
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Skin Resurfacing & Tightening
  • 6.2.2. Body Contouring and Cellulite Reduction
  • 6.2.3. Hair and Tattoo Removal
  • 6.2.4. Breast Augmentation
  • 6.2.5. Other Applications
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Energy-based Aesthetic Devices
    • 7.1.1.1. Laser-based Aesthetic Devices
    • 7.1.1.2. Radiofrequency based Aesthetic Devices
    • 7.1.1.3. Light-based Aesthetic Devices
    • 7.1.1.4. Ultrasound Aesthetic Devices
  • 7.1.2. Non-Energy based Aesthetic Devices
    • 7.1.2.1. Botulinum Toxin
    • 7.1.2.2. Dermal Fillers
    • 7.1.2.3. Microdermabrasion
    • 7.1.2.4. Implants
      • 7.1.2.4.1. Dental Implants
      • 7.1.2.4.2. Breast Implants
      • 7.1.2.4.3. Other Implants
  • 7.1.3. Other Aesthetic Devices
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Skin Resurfacing & Tightening
  • 7.2.2. Body Contouring and Cellulite Reduction
  • 7.2.3. Hair and Tattoo Removal
  • 7.2.4. Breast Augmentation
  • 7.2.5. Other Applications
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. Germany
  • 7.4.2. U.K.
  • 7.4.3. France
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Energy-based Aesthetic Devices
    • 8.1.1.1. Laser-based Aesthetic Devices
    • 8.1.1.2. Radiofrequency based Aesthetic Devices
    • 8.1.1.3. Light-based Aesthetic Devices
    • 8.1.1.4. Ultrasound Aesthetic Devices
  • 8.1.2. Non-Energy based Aesthetic Devices
    • 8.1.2.1. Botulinum Toxin
    • 8.1.2.2. Dermal Fillers
    • 8.1.2.3. Microdermabrasion
    • 8.1.2.4. Implants
      • 8.1.2.4.1. Dental Implants
      • 8.1.2.4.2. Breast Implants
      • 8.1.2.4.3. Other Implants
  • 8.1.3. Other Aesthetic Devices
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Skin Resurfacing & Tightening
  • 8.2.2. Body Contouring and Cellulite Reduction
  • 8.2.3. Hair and Tattoo Removal
  • 8.2.4. Breast Augmentation
  • 8.2.5. Other Applications
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. India
  • 8.4.2. China
  • 8.4.3. Japan
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Energy-based Aesthetic Devices
    • 9.1.1.1. Laser-based Aesthetic Devices
    • 9.1.1.2. Radiofrequency based Aesthetic Devices
    • 9.1.1.3. Light-based Aesthetic Devices
    • 9.1.1.4. Ultrasound Aesthetic Devices
  • 9.1.2. Non-Energy based Aesthetic Devices
    • 9.1.2.1. Botulinum Toxin
    • 9.1.2.2. Dermal Fillers
    • 9.1.2.3. Microdermabrasion
    • 9.1.2.4. Implants
      • 9.1.2.4.1. Dental Implants
      • 9.1.2.4.2. Breast Implants
      • 9.1.2.4.3. Other Implants
  • 9.1.3. Other Aesthetic Devices
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Skin Resurfacing & Tightening
  • 9.2.2. Body Contouring and Cellulite Reduction
  • 9.2.3. Hair and Tattoo Removal
  • 9.2.4. Breast Augmentation
  • 9.2.5. Other Applications
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Medical Aesthetics Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Energy-based Aesthetic Devices
    • 10.1.1.1. Laser-based Aesthetic Devices
    • 10.1.1.2. Radiofrequency based Aesthetic Devices
    • 10.1.1.3. Light-based Aesthetic Devices
    • 10.1.1.4. Ultrasound Aesthetic Devices
  • 10.1.2. Non-Energy based Aesthetic Devices
    • 10.1.2.1. Botulinum Toxin
    • 10.1.2.2. Dermal Fillers
    • 10.1.2.3. Microdermabrasion
    • 10.1.2.4. Implants
      • 10.1.2.4.1. Dental Implants
      • 10.1.2.4.2. Breast Implants
      • 10.1.2.4.3. Other Implants
  • 10.1.3. Other Aesthetic Devices
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Skin Resurfacing & Tightening
  • 10.2.2. Body Contouring and Cellulite Reduction
  • 10.2.3. Hair and Tattoo Removal
  • 10.2.4. Breast Augmentation
  • 10.2.5. Other Applications
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Sisram Medical Ltd
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Merz Pharma
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Apyx Medical
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. AbbVie Inc.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. El.En. S.p.A.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Johnson & Johnson Services, Inc. (MENTOR)
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Candela Medical
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Cutera
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Bausch Health Companies Inc.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Sientra, Inc.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)